A critique of the use of the maximum tolerated dose in bioassays to assess cancer risks from chemicals
- 31 August 1991
- journal article
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 14 (1) , 78-87
- https://doi.org/10.1016/0273-2300(91)90053-x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Too Many Rodent Carcinogens: Mitogenesis Increases MutagenesisScience, 1990
- Cell Proliferation in CarcinogenesisScience, 1990
- The importance of pharmacokinetic and receptor studies in drug safety evaluationRegulatory Toxicology and Pharmacology, 1990
- Uncertainty in health risk assessmentsRegulatory Toxicology and Pharmacology, 1990
- The myth of the final hazard assessmentRegulatory Toxicology and Pharmacology, 1990
- Relevance of maximum tolerated dose to human carcinogenic riskRegulatory Toxicology and Pharmacology, 1990
- Ranking Possible Carcinogenic HazardsScience, 1987
- Aberrant methylation of liver DNA in rats during hepatotoxicityToxicology and Applied Pharmacology, 1981
- History of Drug Metabolism: Discoveries of the Major Pathways in the 19th CenturyDrug Metabolism Reviews, 1977
- Application of Pharmacokinetic Principles in the Extrapolation of Animal Data to HumansClinical Toxicology, 1976